Cargando…

Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study

BACKGROUND & AIMS: Body composition, particularly sarcopenia, is associated with mortality in patients with decompensated cirrhosis undergoing transplant evaluation. Similar data are limited for non-transplant eligible or compensated patients. METHODS: A total of 274 patients with cirrhosis were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tapper, Elliot B., Zhang, Peng, Garg, Rohan, Nault, Tori, Leary, Kate, Krishnamurthy, Venkat, Su, Grace L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005567/ https://www.ncbi.nlm.nih.gov/pubmed/32039402 http://dx.doi.org/10.1016/j.jhepr.2019.11.005

Ejemplares similares

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis
por: Mullin, Monica, et al.
Publicado: (2022)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Portal Venous Remodeling Determines the Pattern of Cirrhosis Decompensation: A Systems Analysis
por: Mazumder, Nikhilesh R., et al.
Publicado: (2023)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis
por: Grace, Josephine A., et al.
Publicado: (2020)

Six-minute walk test predicts future decompensation in patients with compensated liver cirrhosis
por: Henrique, Diane Michela Nery, et al.
Publicado: (2022)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history
por: Romero‐Cristóbal, Mario, et al.
Publicado: (2022)

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy
por: Li, Mingyu, et al.
Publicado: (2023)

Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis
por: Wang, Xiaoyu, et al.
Publicado: (2022)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis
por: Jo, Sang Kyung, et al.
Publicado: (2019)

Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis
por: Zhang, Yue, et al.
Publicado: (2021)

Sarcopenia and frailty combined increases the risk of mortality in patients with decompensated cirrhosis
por: Guo, Gaoyue, et al.
Publicado: (2022)

Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis
por: Kwon, Ji Hye, et al.
Publicado: (2021)

Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701)
por: Yu, Qian, et al.
Publicado: (2022)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
por: Hassan, Elham Ahmed, et al.
Publicado: (2019)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis
por: John, Binu V., et al.
Publicado: (2021)

Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis
por: Matiollo, Camila, et al.
Publicado: (2022)

Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis
por: VoPham, Trang, et al.
Publicado: (2023)

Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis
por: Childs, Kate, et al.
Publicado: (2017)

A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study
por: Groff, Andrew J., et al.
Publicado: (2023)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oo701f3abcv6ivh0r05spepto3